Trial intelligence / Profile preview

Postoperative analgesic effect of lidocaine PCIA in laparoscopic colorectal tumor surgery

ChiCTR2300068854Phase 4Not yet recruiting

Sponsor
Gansu Provincial People's Hospital
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of lidocaine in colorectal cancer (CRC) (2 arms), sponsored by Gansu Provincial People's Hospital. Primary endpoint: Analgesic effect. Planned start Mar 2023; status: not yet recruiting.

02

Drugs

lidocaine
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on ChiCTR2300068854.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300068854.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call